Physician profile
Todd E Niemeier
NPI 1093773400
$968.08
in general payments reported to CMS, 2019-2025
7 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $95.01 · 2021: $104 · 2022: $71.00 · 2023: $124 · 2024: $244 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335 · Entertainment: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.63 |
| Entertainment | $150.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $340.69 | 2020-2025 | Precision7, Total30 |
| Optos, INC. | $221.25 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.04 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $110.29 | 2024 | Xdemvy |
| Allergan, INC. | $101.33 | 2019 | |
| Glaukos Corporation | $67.22 | 2021 | |
| Coopervision INC. | $15.26 | 2023 | Misight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Niemeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.